1. Sacubitril/valsartan in PARADIGM-HF
Nicolas Vodovar, Hélène Nougué, Jean-Marie Launay, Alain Cohen Solal, Damien Logeart 
The Lancet Diabetes & Endocrinology 
Volume 5, Issue 7, Pages (July 2017)
DOI: /S (17)
Copyright © 2017 Elsevier Ltd Terms and Conditions

2. Figure
Concentration of GLP-1 (7–36) amide in plasma from 27 patients before and after sacubitril/valsartan treatment
Circles indicate individual patient data, the central bar is the median, the outer box is the IQR, and whiskers indicate the 1·5 IQR. GLP-1 (7–36) amide=active amidated form of glucagon-like peptide-1.
The Lancet Diabetes & Endocrinology 2017 5, DOI: ( /S (17) )
Copyright © 2017 Elsevier Ltd Terms and Conditions